Optimization of novel pyrido-pyridazinone derivatives as FER tyrosine kinase inhibitor to lead to the clinical candidate (highly potent compound) DS08701581
Taniguchi, T., Yasumatsu, I., Inagaki, H., Baba, D., Toyota, A., Kaneta, Y., Odagiri, T., Momose, T., Kawai, J., Imaoka, T., Nakayama, K.To be published.